Advertisement

Mortality in hemodialysis patients: predict and (trying to) reduce it

Mortality in hemodialysis patients: predict and (trying to) reduce it

Mortalità nei pazienti emodializzati: predirla e (cercare di) ridurla

G Tec Nefrol Dial 2016; 28(1): 56 - 59

Article Type: SPECIAL FOCUS REVIEW

Article Subject: TN&D JOURNAL CLUB

DOI:10.5301/GTND.2016.15548

Authors

Andrea Cavalli, Giuseppe Pontoriero

Abstract

Mortality risk scores for hemodialysis patients have been developed also in the past, but with low clinical applicability. Floege has recently developed a score in 11.500 hemodialysis incident European patients, able to predict mortality risk after 1 and 2 years. The principal determinants of the score were: older age, low body mass index, history of cancer, high levels of C-reactive protein and low levels of albumin. The relevance of the score is due to its high applicability also to an external cohort of hemodialysis patients (the DOPPS study patients). The increased incidence of cancers in hemodialysis patients represents another important situation, in which we need to improve our everyday clinical practice, especially for cancers frequent in dialysis patients (kidney/renal pelvis and bladder), in order to apply adequate screening procedures.

Article History

This article is available as full text PDF.

Download any of the following attachments:

Authors

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.